Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-136 capsules plus sofosbuvir in treatment-naive chronic HCV infection
CTR20170073Phase 2Active
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of coblopasvir, sofosbuvir in chronic hepatitis C (CHC), sponsored by Beijing Kawin Technology Share-Holding Co., Ltd.. Started Mar 2017; status: active.
02
Drugs
coblopasvirsofosbuvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on CTR20170073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170073.